Perspectives on pharmaceutical pricing practices: hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, second session, September 19, 1996, Volume 4
U.S. Government Printing Office, 1996 - Medical - 69 pages
Try this search over all volumes: discriminatory pricing
Results 1-0 of 0
What people are saying - Write a review
We haven't found any reviews in the usual places.
ability able Allen brand name Bristol-Myers Squibb ceutical Chairman class action class of trade community pharmacies community retail pharmacy compete competition consumers contracts counsel discriminatory pricing drug companies drug costs drug makers drug manufacturers Engel enrollees equal access Eshoo Euless Federal Trade Commission formulary Glaxo going Group Health Group Health Cooperative Harmison health insurers hearing HMO's hospitals independent pharmacies issue Jaggar Joe Barton Klink Kocoras lawsuit litigation lower prices Lumpkin macies macist managed care entities marketplace Medicaid million move market share negotiate O'Brien Oversight and Investigations panel patients PBM's percent Pete Allen pharma pharmaceutical pharmaceutical manufacturers pharmaceutical pricing pharmacists pharmacy benefit pharmacy benefit managers physician plaintiffs prescription drug prices prescription drugs price discrimination pricing practices question rebates retail phar Robinson-Patman Act scription drug settlement Silberman statement Summary Judgment testimony Texas Thank there's tion Towler volume wholesalers